company background image
ENFN

Enfusion NYSE:ENFN Stock Report

Last Price

US$10.47

Market Cap

US$1.2b

7D

-6.7%

1Y

n/a

Updated

01 Jul, 2022

Data

Company Financials +
ENFN fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance0/6
Financial Health4/6
Dividends0/6

ENFN Stock Overview

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific.

Enfusion Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Enfusion
Historical stock prices
Current Share PriceUS$10.47
52 Week HighUS$23.21
52 Week LowUS$7.80
Beta0
1 Month Change0.096%
3 Month Change-18.08%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-47.15%

Recent News & Updates

Jun 24

Enfusion: A Compelling Financial SaaS Company

Enfusion is down over 60% since its IPO last year. The company is aiming to disrupt the legacy investment management market with its revamped purpose-built solution. It has a large addressable market as the global AUM and number of firms are continuing to increase. It is showing strong revenue growth and its current valuation is compelling compared to its peers. I rate the company as a buy.

May 10
Estimating The Fair Value Of Enfusion, Inc. (NYSE:ENFN)

Estimating The Fair Value Of Enfusion, Inc. (NYSE:ENFN)

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Enfusion, Inc...

Shareholder Returns

ENFNUS SoftwareUS Market
7D-6.7%-2.2%-0.6%
1Yn/a-23.6%-21.7%

Return vs Industry: Insufficient data to determine how ENFN performed against the US Software industry.

Return vs Market: Insufficient data to determine how ENFN performed against the US Market.

Price Volatility

Is ENFN's price volatile compared to industry and market?
ENFN volatility
ENFN Average Weekly Movement11.8%
Software Industry Average Movement10.9%
Market Average Movement8.0%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.2%

Stable Share Price: ENFN is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: ENFN's weekly volatility (12%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2021892Thomas Kimhttps://www.enfusion.com

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools that allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and execution management system that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. The company also offers accounting/general ledger system, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion analytics system, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services.

Enfusion Fundamentals Summary

How do Enfusion's earnings and revenue compare to its market cap?
ENFN fundamental statistics
Market CapUS$1.15b
Earnings (TTM)-US$199.88m
Revenue (TTM)US$121.49m

5.7x

P/S Ratio

-3.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ENFN income statement (TTM)
RevenueUS$121.49m
Cost of RevenueUS$36.02m
Gross ProfitUS$85.47m
Other ExpensesUS$285.35m
Earnings-US$199.88m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-3.05
Gross Margin70.35%
Net Profit Margin-164.53%
Debt/Equity Ratio0.0%

How did ENFN perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is ENFN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ENFN?

Other financial metrics that can be useful for relative valuation.

ENFN key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue5.4x
Enterprise Value/EBITDA-2.3x
PEG Ration/a

Price to Sales Ratio vs Peers

How does ENFN's PS Ratio compare to its peers?

ENFN PS Ratio vs Peers
The above table shows the PS ratio for ENFN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average7x
EVBG Everbridge
2.9x14.1%US$1.1b
ALKT Alkami Technology
7.7x24.1%US$1.3b
LAW CS Disco
8.3x27.4%US$1.1b
MTTR Matterport
9.2x29.2%US$1.0b
ENFN Enfusion
5.5x26.7%US$1.2b

Price-To-Sales vs Peers: ENFN is good value based on its Price-To-Sales Ratio (5.7x) compared to the peer average (7.2x).


Price to Earnings Ratio vs Industry

How does ENFN's PE Ratio compare vs other companies in the US Software Industry?

Price-To-Sales vs Industry: ENFN is expensive based on its Price-To-Sales Ratio (5.7x) compared to the US Software industry average (4.4x)


Price to Sales Ratio vs Fair Ratio

What is ENFN's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ENFN PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio5.7x
Fair PS Ratio7.2x

Price-To-Sales vs Fair Ratio: ENFN is good value based on its Price-To-Sales Ratio (5.7x) compared to the estimated Fair Price-To-Sales Ratio (7.2x).


Share Price vs Fair Value

What is the Fair Price of ENFN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: ENFN ($10.47) is trading above our estimate of fair value ($10.17)

Significantly Below Fair Value: ENFN is trading above our estimate of fair value.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate ENFN's PEG Ratio to determine if it is good value.


Discover undervalued companies

Future Growth

How is Enfusion forecast to perform in the next 1 to 3 years based on estimates from 7 analysts?

Future Growth Score

2/6

Future Growth Score 2/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


120.9%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: ENFN is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: ENFN is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: ENFN is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: ENFN's revenue (26.7% per year) is forecast to grow faster than the US market (8.2% per year).

High Growth Revenue: ENFN's revenue (26.7% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: ENFN is forecast to be unprofitable in 3 years.


Discover growth companies

Past Performance

How has Enfusion performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-7,146.7%

Last years earnings growth

Earnings and Revenue History

Quality Earnings: ENFN is currently unprofitable.

Growing Profit Margin: ENFN is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if ENFN's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare ENFN's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ENFN is unprofitable, making it difficult to compare its past year earnings growth to the Software industry (26.8%).


Return on Equity

High ROE: ENFN has a negative Return on Equity (-309.05%), as it is currently unprofitable.


Discover strong past performing companies

Financial Health

How is Enfusion's financial position?

Financial Health Score

4/6

Financial Health Score 4/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: ENFN's short term assets ($86.4M) exceed its short term liabilities ($7.7M).

Long Term Liabilities: ENFN's short term assets ($86.4M) exceed its long term liabilities ($497.0K).


Debt to Equity History and Analysis

Debt Level: ENFN is debt free.

Reducing Debt: ENFN had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Insufficient data to determine if ENFN has enough cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if ENFN has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies

Dividend

What is Enfusion current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


0.013%

Forecast Dividend Yield

Dividend Yield vs Market

Notable Dividend: Unable to evaluate ENFN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ENFN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if ENFN's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ENFN's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as ENFN has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

1.2yrs

Average management tenure


CEO

Thomas Kim (49 yo)

2.25yrs

Tenure

Mr. Thomas Kim serves as Chief Executive Officer at Enfusion Ltd. LLC since March 2020. He has been the Chief Executive Officer at Enfusion, Inc since March 2020 and Director since 2021.He was Chief Execu...


Leadership Team

Experienced Management: ENFN's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.


Board Members

Experienced Board: ENFN's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: ENFN only recently listed within the past 12 months.


Top Shareholders

Company Information

Enfusion, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Enfusion, Inc.
  • Ticker: ENFN
  • Exchange: NYSE
  • Founded: 2021
  • Industry: Application Software
  • Sector: Software
  • Implied Market Cap: US$1.154b
  • Market Cap: US$669.605m
  • Shares outstanding: 113.05m
  • Website: https://www.enfusion.com

Number of Employees


Location

  • Enfusion, Inc.
  • 125 South Clark Street
  • Suite 750
  • Chicago
  • Illinois
  • 60603
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/07/01 00:00
End of Day Share Price2022/07/01 00:00
Earnings2022/03/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.